Teladoc Health, Inc. (0LDR.L)
USD 9.55
(-4.89%)
USD 9.55
(-4.89%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.39 Billion USD | 1.08% |
| 2022 | 4.34 Billion USD | -75.5% |
| 2021 | 17.73 Billion USD | -0.12% |
| 2020 | 17.75 Billion USD | 1007.75% |
| 2019 | 1.6 Billion USD | 4.84% |
| 2018 | 1.52 Billion USD | 85.46% |
| 2017 | 824.39 Million USD | 171.48% |
| 2016 | 303.67 Million USD | 32.18% |
| 2015 | 229.73 Million USD | 149.7% |
| 2014 | 92 Million USD | 235.96% |
| 2013 | 27.38 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 3.52 Billion USD | 0.14% |
| 2024 Q1 | 4.32 Billion USD | -1.63% |
| 2024 Q2 | 3.52 Billion USD | -18.45% |
| 2023 Q3 | 4.32 Billion USD | 0.27% |
| 2023 Q4 | 4.39 Billion USD | 1.49% |
| 2023 FY | 4.39 Billion USD | 1.08% |
| 2023 Q1 | 4.3 Billion USD | -0.83% |
| 2023 Q2 | 4.31 Billion USD | 0.17% |
| 2022 Q2 | 8.1 Billion USD | -26.95% |
| 2022 Q1 | 11.09 Billion USD | -37.45% |
| 2022 Q4 | 4.34 Billion USD | -46.38% |
| 2022 FY | 4.34 Billion USD | -75.5% |
| 2022 Q3 | 8.1 Billion USD | 0.01% |
| 2021 Q4 | 17.73 Billion USD | 0.46% |
| 2021 Q2 | 17.61 Billion USD | 0.16% |
| 2021 Q3 | 17.65 Billion USD | 0.24% |
| 2021 FY | 17.73 Billion USD | -0.12% |
| 2021 Q1 | 17.58 Billion USD | -0.97% |
| 2020 Q4 | 17.75 Billion USD | 414.74% |
| 2020 FY | 17.75 Billion USD | 1007.75% |
| 2020 Q3 | 3.44 Billion USD | 42.61% |
| 2020 Q2 | 2.41 Billion USD | 50.89% |
| 2020 Q1 | 1.6 Billion USD | 0.02% |
| 2019 Q3 | 1.56 Billion USD | 0.2% |
| 2019 Q1 | 1.55 Billion USD | 1.49% |
| 2019 Q2 | 1.56 Billion USD | 0.88% |
| 2019 FY | 1.6 Billion USD | 4.84% |
| 2019 Q4 | 1.6 Billion USD | 2.19% |
| 2018 Q2 | 1.19 Billion USD | 46.77% |
| 2018 Q3 | 1.53 Billion USD | 27.94% |
| 2018 FY | 1.52 Billion USD | 85.46% |
| 2018 Q4 | 1.52 Billion USD | -0.41% |
| 2018 Q1 | 817.52 Million USD | -0.83% |
| 2017 Q2 | 674.14 Million USD | 62.86% |
| 2017 Q1 | 413.95 Million USD | 36.32% |
| 2017 FY | 824.39 Million USD | 171.48% |
| 2017 Q4 | 824.39 Million USD | -6.42% |
| 2017 Q3 | 880.92 Million USD | 30.67% |
| 2016 Q1 | 213.48 Million USD | -7.08% |
| 2016 Q2 | 203.89 Million USD | -4.49% |
| 2016 FY | 303.67 Million USD | 32.18% |
| 2016 Q4 | 303.67 Million USD | -3.06% |
| 2016 Q3 | 313.26 Million USD | 53.65% |
| 2015 Q4 | 229.73 Million USD | -5.57% |
| 2015 Q3 | 243.28 Million USD | 127.49% |
| 2015 Q2 | 106.94 Million USD | 22.41% |
| 2015 Q1 | 87.36 Million USD | -5.05% |
| 2015 FY | 229.73 Million USD | 149.7% |
| 2014 Q4 | 92 Million USD | 0.0% |
| 2014 FY | 92 Million USD | 235.96% |
| 2014 Q1 | - USD | 0.0% |
| 2013 FY | 27.38 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -1083.656% |
| Accuray Incorporated | 468.62 Million USD | -837.285% |
| Align Technology, Inc. | 6.08 Billion USD | 27.803% |
| Elevance Health Inc. | 108.92 Billion USD | 95.968% |
| AxoGen, Inc. | 196.82 Million USD | -2131.589% |
| Boston Scientific Corporation | 35.13 Billion USD | 87.499% |
| CVS Health Corporation | 249.72 Billion USD | 98.241% |
| Cardinal Health, Inc. | 45.12 Billion USD | 90.265% |
| Centene Corporation | 84.64 Billion USD | 94.811% |
| DaVita Inc. | 17.61 Billion USD | 75.071% |
| HCA Healthcare, Inc. | 56.21 Billion USD | 92.186% |
| Hologic, Inc. | 9.15 Billion USD | 52.027% |
| Humana Inc. | 47.06 Billion USD | 90.667% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -34.738% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | 73.738% |
| Masimo Corporation | 3.04 Billion USD | -44.415% |
| McKesson Corporation | 67.44 Billion USD | 93.487% |
| Patterson Companies, Inc. | 2.96 Billion USD | -47.938% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | 68.675% |
| ResMed Inc. | 6.87 Billion USD | 36.087% |
| Henry Schein, Inc. | 10.57 Billion USD | 58.457% |
| Universal Health Services, Inc. | 14.35 Billion USD | 69.406% |
| Veeva Systems Inc. | 5.91 Billion USD | 25.691% |
| Baxter International Inc. | 28.27 Billion USD | 84.466% |
| Becton, Dickinson and Company | 52.78 Billion USD | 91.678% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 71.555% |
| Danaher Corporation | 84.48 Billion USD | 94.801% |
| Stryker Corporation | 39.91 Billion USD | 88.995% |
| Medtronic plc | 89.98 Billion USD | 95.119% |